These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 10805476

  • 21. Casebook: proteinuria.
    de Zoysa JR, Harris KP.
    Practitioner; 2003 Nov; 247(1652):860-2, 866, 870 passim. PubMed ID: 14640049
    [No Abstract] [Full Text] [Related]

  • 22. Reply to the letter from G. Smith. Angiotensin converting enzyme inhibitor (ACEI) and reflux nephropathy.
    Lama G, Salsano ME, Pedullà M, Grassia C, Ruocco G.
    Pediatr Nephrol; 1999 Aug; 13(6):552. PubMed ID: 10452288
    [No Abstract] [Full Text] [Related]

  • 23. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M, Rutkowski P, Tylicki L, Zietkiewicz M, Larczyński W, Rutkowski B.
    Przegl Lek; 2008 Mar; 65(6):312-4. PubMed ID: 18853664
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Kidney failure, proteinuria, and diabetic nephropathy].
    Collart F.
    Rev Med Brux; 2003 Sep; 24(4):A257-62. PubMed ID: 14606290
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.
    Boero R, Rollino C, Massara C, Vagelli G, Gonella M, Berto IM, Bajardi P, Perosa P, Malcangi U, Giorgi MP, Ghezzi PM, Borzumati M, Baroni AM, Cogno C, Triolo G, Angelini D, Antonelli A, Quarello F.
    J Nephrol; 2001 Sep; 14(1):15-8. PubMed ID: 11281338
    [Abstract] [Full Text] [Related]

  • 31. [Effects of benazepril and valsartan alone or in combination on proteinuria in chronic glomerular disease].
    Zhang DY, Yang YL, Chen WD, Huang YY, Li LH, Wang YW, Zhu XJ, Xu HH, Yang LC.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):762-3. PubMed ID: 18093443
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
    Esnault V.
    Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Is angiotensin-converting enzyme inhibitor appropriate for contrast-induced nephropathy? A meta-analysis about this field.
    Li X, Li T, Fu N, Hu Y, Cong H.
    Int J Cardiol; 2012 Mar 22; 155(3):486-8. PubMed ID: 22264872
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Obstructive nephropathy and the developing kidney: too little or too much angiotensin?
    Chevalier RL.
    Kidney Int; 2004 Apr 22; 65(4):1517-8. PubMed ID: 15086496
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.